novartis holding ag charge will be taken on antiviral generic swiss pharmaceuticals company novartis holding ag said it will take a third quarter charge of &# million to &# million related to the introduction of a generic version of its antiviral drug famvir israeli drug company teva pharmaceuticals industries ltd said it is planning a generic version of famvir novartis said that some of famvirs u s patents were valid until and that it will keep defending its intellectual property the two companies have been in patent litigation since a new trial date has yet to be set 
